Categories Articles Eli Lilly’s Wegovy rival Zepbound will help make weight-loss drug market worth $130 billion by 2030, Goldman Sachs says Post author By crystalg Post date June 1, 2024 Business Insider Business Insider Tags $130, 2030, billion, drug, Goldman, Help, Lilly’s, Market, rival, Sachs, Says, Wegovy, weightloss, Worth, Zepbound ← You Might See More Orange Juice Mixed With Other Fruit on Store Shelves — Here’s Why → Hostage Families Call For Biden-Backed Cease-Fire Deal. Israel Says Conditions Must be Met